Intellia Therapeutics Inc buy melinda
Start price
08.03.18
/
50%
€28.31
Target price
10.09.18
€68.55
Performance (%)
-13.22%
End price
10.09.18
€24.57
Summary
This prediction ended on 10.09.18 with a price of €24.57. The price of Intellia Therapeutics Inc has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -13.22%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Intellia Therapeutics Inc | -6.447% | -6.447% | 6.454% | -74.618% |
| iShares Core DAX® | 1.085% | -0.846% | 12.464% | 58.472% |
| iShares Nasdaq 100 | -1.665% | -3.306% | 1.502% | 84.473% |
| iShares Nikkei 225® | 3.863% | 6.308% | 22.272% | 56.185% |
| iShares S&P 500 | 0.111% | -1.337% | 1.101% | 58.320% |
According to melinda what are the pros and cons of Intellia Therapeutics Inc for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Biotechnologie und Medizintechnik SecteurRecherche Agenda 13/03 | 20.50 Präsentation
mehr
$ NTLA mit einem Outperform bei JMP Initiiert & $ 76 PT
(Laufzeit überschritten)
Stopped prediction by melinda for Intellia Therapeutics Inc
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€18.68
21.05.20
21.05.20
€30.00
04.11.21
04.11.21
531.06%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
